Formulation, characterization and evaluation of morusin loaded niosomes for potentiation of anticancer therapy

Srishti Agarwal, M. Sheikh Mohamed, Sreejith Raveendran, Ankit K. Rochani, Toru Maekawa, D. Sakthi Kumar

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Morusin, a water-insoluble prenylated flavonoid is known for its numerous medicinal properties. It manifests its anticancer potential by suppression of genes involved in tumor progression. However, poor solubility of the drug results in low bioavailability and rapid degradation thus hindering its clinical utilization. In order to overcome this, we have synthesized a niosome system composed of non-ionic surfactant span 60 and cholesterol using a thin-layer evaporation technique to improve the aqueous-phase solubility of the drug. Highly cytocompatible niosomes of 479 nm average size with smooth and uniform spherical morphology were synthesized in a facile manner. Unlike free morusin, nanomorusin was found to be freely dispersible in aqueous media. Having an extremely high drug entrapment efficiency (97%), controlled and sustained release of morusin resulting in enhanced therapeutic efficacy was observed in cancer cell lines of 4 different lineages. The results demonstrate that the morusin-niosome system is a promising strategy for enhanced anti-cancer activity against multiple cancer types and could be an indispensable tool for future targeted chemotherapeutic strategies.

Original languageEnglish
Pages (from-to)32621-32636
Number of pages16
JournalRSC Advances
Volume8
Issue number57
DOIs
Publication statusPublished - 21 Sep 2018

Fingerprint

Liposomes
Solubility
Flavonoids
Cholesterol
Nonionic surfactants
Tumors
Evaporation
Genes
Cells
Pharmaceutical Preparations
Degradation
Water
morusin
Biological Availability

Bibliographical note

This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence.

Cite this

Agarwal, Srishti ; Mohamed, M. Sheikh ; Raveendran, Sreejith ; Rochani, Ankit K. ; Maekawa, Toru ; Kumar, D. Sakthi. / Formulation, characterization and evaluation of morusin loaded niosomes for potentiation of anticancer therapy. 2018 ; Vol. 8, No. 57. pp. 32621-32636.
@article{c813e47a6d2b446a831a8e7aec6ec3d4,
title = "Formulation, characterization and evaluation of morusin loaded niosomes for potentiation of anticancer therapy",
abstract = "Morusin, a water-insoluble prenylated flavonoid is known for its numerous medicinal properties. It manifests its anticancer potential by suppression of genes involved in tumor progression. However, poor solubility of the drug results in low bioavailability and rapid degradation thus hindering its clinical utilization. In order to overcome this, we have synthesized a niosome system composed of non-ionic surfactant span 60 and cholesterol using a thin-layer evaporation technique to improve the aqueous-phase solubility of the drug. Highly cytocompatible niosomes of 479 nm average size with smooth and uniform spherical morphology were synthesized in a facile manner. Unlike free morusin, nanomorusin was found to be freely dispersible in aqueous media. Having an extremely high drug entrapment efficiency (97{\%}), controlled and sustained release of morusin resulting in enhanced therapeutic efficacy was observed in cancer cell lines of 4 different lineages. The results demonstrate that the morusin-niosome system is a promising strategy for enhanced anti-cancer activity against multiple cancer types and could be an indispensable tool for future targeted chemotherapeutic strategies.",
author = "Srishti Agarwal and Mohamed, {M. Sheikh} and Sreejith Raveendran and Rochani, {Ankit K.} and Toru Maekawa and Kumar, {D. Sakthi}",
note = "This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence.",
year = "2018",
month = "9",
day = "21",
doi = "10.1039/c8ra06362a",
language = "English",
volume = "8",
pages = "32621--32636",
number = "57",

}

Formulation, characterization and evaluation of morusin loaded niosomes for potentiation of anticancer therapy. / Agarwal, Srishti; Mohamed, M. Sheikh; Raveendran, Sreejith; Rochani, Ankit K.; Maekawa, Toru; Kumar, D. Sakthi.

Vol. 8, No. 57, 21.09.2018, p. 32621-32636.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Formulation, characterization and evaluation of morusin loaded niosomes for potentiation of anticancer therapy

AU - Agarwal, Srishti

AU - Mohamed, M. Sheikh

AU - Raveendran, Sreejith

AU - Rochani, Ankit K.

AU - Maekawa, Toru

AU - Kumar, D. Sakthi

N1 - This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence.

PY - 2018/9/21

Y1 - 2018/9/21

N2 - Morusin, a water-insoluble prenylated flavonoid is known for its numerous medicinal properties. It manifests its anticancer potential by suppression of genes involved in tumor progression. However, poor solubility of the drug results in low bioavailability and rapid degradation thus hindering its clinical utilization. In order to overcome this, we have synthesized a niosome system composed of non-ionic surfactant span 60 and cholesterol using a thin-layer evaporation technique to improve the aqueous-phase solubility of the drug. Highly cytocompatible niosomes of 479 nm average size with smooth and uniform spherical morphology were synthesized in a facile manner. Unlike free morusin, nanomorusin was found to be freely dispersible in aqueous media. Having an extremely high drug entrapment efficiency (97%), controlled and sustained release of morusin resulting in enhanced therapeutic efficacy was observed in cancer cell lines of 4 different lineages. The results demonstrate that the morusin-niosome system is a promising strategy for enhanced anti-cancer activity against multiple cancer types and could be an indispensable tool for future targeted chemotherapeutic strategies.

AB - Morusin, a water-insoluble prenylated flavonoid is known for its numerous medicinal properties. It manifests its anticancer potential by suppression of genes involved in tumor progression. However, poor solubility of the drug results in low bioavailability and rapid degradation thus hindering its clinical utilization. In order to overcome this, we have synthesized a niosome system composed of non-ionic surfactant span 60 and cholesterol using a thin-layer evaporation technique to improve the aqueous-phase solubility of the drug. Highly cytocompatible niosomes of 479 nm average size with smooth and uniform spherical morphology were synthesized in a facile manner. Unlike free morusin, nanomorusin was found to be freely dispersible in aqueous media. Having an extremely high drug entrapment efficiency (97%), controlled and sustained release of morusin resulting in enhanced therapeutic efficacy was observed in cancer cell lines of 4 different lineages. The results demonstrate that the morusin-niosome system is a promising strategy for enhanced anti-cancer activity against multiple cancer types and could be an indispensable tool for future targeted chemotherapeutic strategies.

UR - http://www.scopus.com/inward/record.url?scp=85054160533&partnerID=8YFLogxK

U2 - 10.1039/c8ra06362a

DO - 10.1039/c8ra06362a

M3 - Article

VL - 8

SP - 32621

EP - 32636

IS - 57

ER -